Clinical significance of circulating immune complexes and components of the blood complement system in viral meningitis in children
https://doi.org/10.51793/OS.2024.27.1.002
Abstract
Background. Neuroinfections are one of the global medical and social problems of pediatrics, due to the high incidence of neurological complications that affect the further development of the child.
Objective. To establish the clinical significance of the concentration of circulating immune complexes (CIC) and C3a, C4, C1inh components of the blood complement system in viral meningitis (VM) in children.
Materials and methods. The study was conducted in 115 patients with CM of various etiologies (enteroviral – 40, arbovirus – 39, mumps – 36) children aged 2 to 14 years. Of these, in 78 (68%) CM proceeded in a moderate form. The etiology of meningitis was determined by PCR-reaction and/or ELISA of cerebrospinal fluid (CSF) and/or blood. As the main target laboratory parameters, the concentration of complement components: C1inh, C4, C3a in blood plasma was determined by ELISA using the kits of reagents «ELISA-Clinh», «ELISA-C4», «ELISA-C3a». The determination of CEC in blood serum was carried out in the immunoprecipitation reaction using 3% and 4% concentrations of polyethylene glycol (PEG) – 6000.
Results. The acute period of severe forms of CM is characterized by an increase in the total amount of CIC up to 14.7 ± 1.2 U/ml, C3a up to 348.7 ± 65.4, C4 up to 319.9 ± 56.4, C1inh up to 405.2 ± 52 .9 μg/ml. With moderate CM, the total CEC pool was 7.3 ± 0.45 IU/ml (p < 0.05), and there were no statistically significant differences in terms of complement fractions. In the period of convalescence of severe forms of CM, the total amount of CIC decreased to 8.1 ± 0.8 U/ml, C3a to 319.3, C4 up to 289.6, C1inh up to 354.6 μg/ml. In moderate CM, CIC decreased to 5.1 ± 0.56 U/ml, C3a increased to 302.5 ± 96.8, C1inh to 434.4 ± 76.5 μg/ml, and C4 decreased to 272.3 ± 42.1 μg/ml compared with the acute period (p > 0.5), remaining higher than the control group, regardless of the severity of the disease. In patients with a protracted course of CM, the C1inh index was 478.2 ± 84.9 μg/ml, C3a was 229.7 ± 44.6 ng/ml, which is 5 and 1.1 times higher, and C4 was 231.5 ± 28.9 μg/ml, 1.1 times lower than in the control group. The concentration of the C1inh fraction of the complement system – 478.2 ± 84.9 μg/ml and CIC – 2.7 ± 0.5 U/ml had a direct correlation with the protracted course of CM (r = 0.685; p = 0.0456)
Conclusion. According to the results of the study, an increase in the concentration of CEC and fractions of the complement system C3a, C4, C1inh in the blood was established, depending on the severity, period, course of the disease, indicating their participation in the development and maintenance of the inflammatory process in patients with CM. There was no normalization of the CIC and complement system parameters during the period of convalescence, and their imbalance during this period may indicate ongoing changes in the tissues of the focus of the inflammatory process and the effectiveness of the therapy.
About the Authors
G. A. KharchenkoРоссия
Gennady A. Kharchenko, Dr. of Sci. (Med.), Professor, Head of the Department of Pediatric Infections
121 Bakinskaya str., Astrakhan, 414000
O. G. Kimirilova
Россия
Olga G. Kimirilova, Cand. of Sci. (Med.), Associate Professor of the Department of Pediatric Infections
121 Bakinskaya str., Astrakhan, 414000
References
1. Lobzin Yu. V., Rychkova S. V., Uskov A. N., Skripchenko N. V., Fedorov V. V. Current trends in infectious morbidity in children in the Russian Federation. Kubanskij nauchnyj medicinskij vestnik. 2020; 27 (4): 119-133. (In Russ.)
2. Majer A., McGreevy T. F. Molecular Pathogenicity of Enteroviruses Causing Neurological Disease. Booth Frontiers in Microbiology. 2020; 11: 540.
3. Romanenkova N. I., Golicina N., Bichurina M. A., et al. The incidence of enterovirus infection and the features of the circulation of enteroviruses in some territories of Russia in 2017. Zhurnal infektologii. 2018; 10 (4):124-133. (In Russ.)
4. Morozova E. A., Ertahova M. L. Outcomes of neuroinfections and their predictors. Russkij zhurnal detskoj nevrologii. 2020; 15 (3-4): 55-64. (In Russ.)
5. Sokolova V. I., Sychev D. A., Vasil'eva E. I., Seredkin E. P. Meningitis: diagnostic difficulties, clinic, treatment. Antibiotiki i himioterapiya. 2019; 9-10 (64): 26-32. (In Russ.)
6. Gussoeva I. G., Albegova B. Z., Alagova M. V., Kokoeva Z. R. Epidemiological features and clinical and laboratory manifestations of serous meningitis of enteroviral etiology. Materialy XIX Kongressa detskih infekcionistov Rossii. Moskva, 2020. Р. 46-47. (In Russ.)
7. Ellul M., Solomon T. Acute encephalitis – diagnosis and management. Clinical Medicine Journal (London). 2018; 2 (18): 155-159.
8. Chen B. S., Lee H. C., Lee K. M., et al. Enterovirus and Encephalitis. Frontiers in Microbiology. 2020; 11: 261.
9. Skripchenko N. V., Vil'nic A. A., Egorova E. S., Skripchenko E. Yu. Emergency conditions in neuroinfections in children. Ross. pediatricheskij zhurnal. 2022; 1 (3): 287. (In Russ.)
10. Molochnyj V. P., Protasenya I. I., Solodovnikov O. N. Microbicidal activity of neutrophil leukocytes in the blood and cerebrospinal fluid of children with enterovirus meningitis. Dal'nevostochnyj zhurnal infekcionnoj patologii. 2015; 28: 34-37. (In Russ.)
11. Kimirilova O. G., Harchenko G. A. Clinical significance of determining the level of immunochemical markers of inflammation in blood serum in viral meningitis in children. Ross. vestn. perinatol. i pediatrii. 2020; 6 (65): 50-56. (In Russ.)
12. Alekseeva L. A., Zheleznikova G. F., Gorelik E. Yu., Skripchenko N. V. Cytokines and neurospecific proteins in viral encephalitis and convulsive syndrome in children. Infekcii i immunitet. 2021; 1 (3): 443-446. (In Russ.)
13. Korolevskaya L. B., Sajdakova E. V., SHmagel' K. V., SHmagel' N. G. Immune complexes and their role in the activation of immunity in HIV infection. Tihookeanskij medicinskij zhurnal. 2018; 4: 41-44. (In Russ.)
14. Wener M. H. Tests for circulating immune complexes. Methods Mol. Biol. 2014; 1134: 47-57.
15. Lesnik E. V., Ginda S. S. CEC as a biomarker of endogenous intoxication in pulmonary tuberculosis. Infekciya i immunitet. 2022; 3 (12): 486-494. (In Russ.)
16. Bayly-Jones С., Bubeck D., Dunstone М. А. The mystery behind membrane insertion: A review of the complement membrane attack complex. Philos. Trans. R. Soc. BBiol. Sci. 2017; 372: 1726.
17. Umnyakova E. S. Modulation of the complement system by antimicrobial peptides. Avtoref…k.m.n. Moskva, 2018. 24 s. (In Russ.)
18. Korolevskaya L. B., Shmagel' K. V. Determination of the size of immune complexes by spectroturbidinmetry. Rossijskij allergologicheskij zhurnal. 2010; 1 (1): 87-88. (In Russ.)
19. Crnogorac M., Horvatic I., Kacinari P., et al. Serum C3 complement levels in ANCA associated vasculitis at diagnosis is a predictor of patient and renal out-come. J. Nephrol. 2018; 2 (31): 257-262.
20. Berlov M. N., Umnyakova E. S., Kokryakov V. N. Neutrophil proteins and peptides in complement regulation. Patogenez. 2017; 1 (15): 19-23. (In Russ.)
21. Khan M. A., Assiri A. M., Broering D. C. Complement mediators: Key regulators of airway tissue remodeling in asthma. J. Transl. Med. 2015; 1 (13): 1-9.
Review
For citations:
Kharchenko G.A., Kimirilova O.G. Clinical significance of circulating immune complexes and components of the blood complement system in viral meningitis in children. Lechaschi Vrach. 2024;(1):16-20. (In Russ.) https://doi.org/10.51793/OS.2024.27.1.002
JATS XML



















